Hsbc Holdings PLC Vbi Vaccines Inc Transaction History

Hsbc Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.66 - $1.81 $2,488 - $6,823	-3,770 Reduced 2.87%	127,718 $103,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $236 - $459	186 Added 0.14%	131,488 $218,000
Q4 2021 Feb 11, 2022	BUY	$2.21 - $3.22 $15,662 - $22,820	7,087 Added 5.71%	131,302 $307,000
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $4,642 - $6,167	-1,658 Reduced 1.32%	124,215 $386,000
Q2 2021 Aug 13, 2021	BUY	$2.61 - $4.17 $24,333 - $38,876	9,323 Added 8.0%	125,873 $421,000
Q1 2021 May 14, 2021	SELL	$2.91 - $4.32 $45,730 - $67,888	-15,715 Reduced 11.88%	116,550 $362,000
Q4 2020 Feb 12, 2021	BUY	$2.15 - $3.5 $284,369 - $462,927	132,265 New	132,265 $363,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.